Please see below for our usual MicroQuad and other weekly data updates. Barring future Monday morning earnings turbulence of the magnitude experienced today, this data will be released earlier (before the open), either as a part of the AM note or a standalone (pending feedback on this version of it). As always, email us if you have any questions on any of the data or our takeaways. - .
KEY CALL OUT
The Consensus 2Q22 estimate ticked higher and it looks like FY 2022 estimates are somewhat reluctantly "rolling with." Watch this trend closely, as it will help support or tank Health Care stocks as we cycle through MacroQuad 3 here in 3Q21.
ESTIMATE REVISION TREND
The Estimate Revision trend looks better week-over-week - can the slope turn positive? It's getting close.
MICROQUADS* & BACKTESTS
As a reminder, if you have questions about the MicroQuad process, please try to find ~20 minutes to watch our Dec 30, 2020 call replay: Process & Utility of the Hedgeye Health Care #MicroQuads - CLICK HERE for event details (includes video link and materials link).
There are fewer names in MQ4 and things cycle around, and what's left in there makes sense from a COVID-comp perspective. The MQ1 bin and potential for some of those stocks to move to MQ2 is what we're most excited about.
PM SIGMA AND PROSPECTIVE PRICE CHANGE
With the exception of ONEM, lots of Green to look forward to here, in our opinion.
MICROQUAD WATCHLIST
TOP & BOTTOM 20 LISTS
All data available upon request. Please reach out to with any feedback or inquiries.
Best,
Thomas Tobin
Managing Director
Twitter
LinkedIn
William McMahon
Analyst
Twitter
LinkedIn
Justin Venneri
Director, Primary Research
Twitter
LinkedIn
*Please note, not all Position Monitor names make it into the MicroQuad output - most likely due to a lack of sufficient historical trading and estimate data.
